AbbVie, Genmab Announces Positive Results From Phase 1/2 Trial Of Epcoritamab
COPENHAGEN (dpa-AFX) - AbbVie (ABBV) and Genmab (GMAB) announced positive results from the follicular lymphoma or FL cohort of the…
166,830€
-0,46%
Echtzeit-Aktienkurs Abbvie Inc.
Bid:
Ask:
Nachrichten zur Abbvie Inc. Aktie
What Will AbbVie Buy Next?
Two mid-cap drugmakers stand out as logical targets for AbbVie....…
The Zacks Analyst Blog Highlights Novo Nordisk, Home Depot, Disney, AbbVie and Automatic Data Processing
Novo Nordisk, Home Depot, Disney, AbbVie and Automatic Data Processing are included in this Analyst Blog....…
AbbVie Announces Positive Results From Phase 1/2 Trial Of Epcoritamab In R/R Follicular Lymphoma
COPENHAGEN (dpa-AFX) - AbbVie (ABBV) and Genmab (GMAB) announced positive results from the follicular lymphoma or FL cohort of the…
AbbVie, Genmab Need Further Follow Up on Trial for Follicular Lymphoma Treatment
AbbVie, Genmab Need Further Follow Up on Trial for Follicular Lymphoma Treatment...…
Genmab and AbbVie Announce Positive Topline Results from Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody® CD3xCD20) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
Company Announcement...…
AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know
AbbVie (ABBV) closed the most recent trading day at $134.95, moving -0.71% from the previous trading session....…
CollPlant nabs $10M milestone from AbbVie for dermal filler product
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie (ABBV) Gets CHMP Positive Opinion for Atogepant Approval
AbbVie (ABBV) receives a positive recommendation from the European Unions medicinal products committee for the approval of its migraine treatment…
AbbVie: Weitere Anhebung der Dividende - Aktienanalyse
Kulmbach (www.aktiencheck.de) - AbbVie-Aktienanalyse von "Der Aktionär":
Michael Diertl vom Anlegermagazin "Der Aktionär" nimmt die Aktie des Pharmakonzerns AbbVie Inc. (ISIN:…
AbbVie: Dividende erhöht – Stimmt das Gesamtbild?
Wie auch die Aktien anderer Schwergewichte im Pharma- und Biotech-Sektor befindet sich AbbVie seit Jahresbeginn deutlich im Minus. Dennoch ließ…
AbbVie migraine therapy endorsed in Europe
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Gets Positive CHMP Opinion For Migraine Treatment
AbbVie Gets Positive CHMP Opinion For Migraine Treatment...…
AbbVie declares $1.48 dividend
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill., June 22, 2023 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a…
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…
The Zacks Analyst Blog Highlights PepsiCo, AbbVie, Honeywell, Salesforce and Goldman Sachs
PepsiCo, AbbVie, Honeywell, Salesforce and Goldman Sachs are included in this Analyst Blog....…
Top Analyst Reports for PepsiCo, AbbVie & Honeywell
Todays Research Daily features new research reports on 16 major stocks, including PepsiCo, Inc. (PEP), AbbVie Inc. (ABBV) and Honeywell…
UPDATE 1-Coherus resolves part of dispute with AbbVie over Humira biosimilar
... in paragraph 6)
June 15 (Reuters) - Coherus BioSciences said......…
AbbVie: Risankizumab Meets Endpoint In Phase 3 Maintenance Study In Ulcerative Colitis Patients
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - AbbVie (ABBV) reported positive top-line results from COMMAND, Phase 3 maintenance study, showing risankizumab achieved the primary…
AbbVie, Coherus in legal battle over Humira biosimilar
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Abbvie, Coherus agree to resolve dispute over Humira biosimilar
...(Reuters) - Coherus BioSciences Inc said on Thursday it had... the licensing agreement.
AbbVie did not…
BEIGENE On Reported Brukinsa Infringement: To React when Appropriate with Vigorous Defense
BEIGENE (06160.HK)'s blood cancer drug "Brukinsa" was purportedly sued for infringement. In response, the company said it will react to…
Ironwood (IRWD), AbbVie Get FDA Nod for Linzess Label Expansion
Ironwood (IRWD) lead drug Linzess gets FDA approval for pediatric functional constipation The label expansion of the drug is expected…
Final Trades: Abbvie, Broadcom, Deere
The "Halftime Report" traders give their top picks to watch for the second half....…
Better Long-Term Buy: AbbVie or Novo Nordisk?
Its important to factor in a pharmaceutical companys pipeline depth....…
Teva, Walgreens, CVS, AbbVie to pay $17.3B in national opioid settlement
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…
AbbVie, Amgen among firms targeted for Medicare inflation penalties
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Is AbbVie or Amgen the Better Bargain Buy Right Now?
These elite drugmakers are both working through a number of headwinds....…
Mozart Therapeutics Raises $25 Million in Expanded Series A Financing to Support Clinical Development of First-in-Class CD8 Treg Modulators for the Treatment of Autoimmune Diseases
Funding supports clinical development of first therapeutic candidate and pipeline expansion Marie-Claire Peakman, PhD, Partner, Pfizer Ventures, and Jasmina Marjanovic,…
AbbVie, Amgen hit 52-week lows as Coherus unveils cheapest Humira version
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why AbbVie and Amgen Are Moving Lower Today
An ultra-low-priced biosimilar may negatively impact both biotechs....…
Mark Cuban online pharmacy to offer AbbVie Humira biosimilar
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca halts AbbVie-partnered bowel disease drug program
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie meets key goals for Rinvoq in mid-stage SLE trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Says Upadacitinib 30 Mg Meets Primary Goals In SLE Patients In Mid-stage Study
WASHINGTON (dpa-AFX) - AbbVie Inc. (ABBV), a clinical-stage pharmaceutical company, Wednesday announced the results of its phase 2 SLEek study…
Übernahme von Botox-Hersteller gibt AbbVie Schub
Frankfurt (Reuters) - Der US-Pharmakonzern AbbVie profitiert von einer hohen Nachfrage nach seinem Blockbuster-Medikament Humira und der Übernahme des Botox-Herstellers…
Agentur - Boehringer und AbbVie in Gesprächen über Krebs-Allianz
Bangalore (Reuters) - Deutschlands zweitgrößter Pharmakonzern Boehringer Ingelheim steht einem Agenturbericht zufolge vor einer umfassenden Partnerschaft bei Krebs-Therapien mit dem…